Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Structure Therapeutics Inc
Recent news which mentions Structure Therapeutics Inc
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
August 24, 2025
Tags
Biotechnology
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
Structure Therapeutics Inc
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
Tags
Roche Holding AG
Breaking News: Business
Health & Science
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
Alphabet Inc
Zealand Pharma A/S
Science
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Amgen Inc
Health & Science
Eli Lilly and Co
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Health & Science
Roche Holding AG
Structure Therapeutics Inc
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Biotechnology
Altimmune Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Pfizer Inc
Structure Therapeutics Inc
Breaking news
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.